These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Uncoupling of the noradrenergic-hypothalamic-pituitary-adrenal axis in panic disorder patients. Coplan JD; Pine D; Papp L; Martinez J; Cooper T; Rosenblum LA; Gorman JM Neuropsychopharmacology; 1995 Aug; 13(1):65-73. PubMed ID: 8526972 [TBL] [Abstract][Full Text] [Related]
9. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Krystal JH; Abi-Saab W; Perry E; D'Souza DC; Liu N; Gueorguieva R; McDougall L; Hunsberger T; Belger A; Levine L; Breier A Psychopharmacology (Berl); 2005 Apr; 179(1):303-9. PubMed ID: 15309376 [TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone. Vythilingam M; Anderson GM; Owens MJ; Halaszynski TM; Bremner JD; Carpenter LL; Heninger GR; Nemeroff CB; Charney DS J Clin Endocrinol Metab; 2000 Nov; 85(11):4138-45. PubMed ID: 11095445 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039). Rorick-Kehn LM; Johnson BG; Burkey JL; Wright RA; Calligaro DO; Marek GJ; Nisenbaum ES; Catlow JT; Kingston AE; Giera DD; Herin MF; Monn JA; McKinzie DL; Schoepp DD J Pharmacol Exp Ther; 2007 Apr; 321(1):308-17. PubMed ID: 17204749 [TBL] [Abstract][Full Text] [Related]
12. Noradrenergic dysregulation during discontinuation of cocaine use in addicts. McDougle CJ; Black JE; Malison RT; Zimmermann RC; Kosten TR; Heninger GR; Price LH Arch Gen Psychiatry; 1994 Sep; 51(9):713-9. PubMed ID: 8080348 [TBL] [Abstract][Full Text] [Related]
14. Plasma MHPG response to yohimbine treatment in women with hypoactive sexual desire. Piletz JE; Segraves KB; Feng YZ; Maguire E; Dunger B; Halaris A J Sex Marital Ther; 1998; 24(1):43-54. PubMed ID: 9509380 [TBL] [Abstract][Full Text] [Related]
15. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice. Linden AM; Shannon H; Baez M; Yu JL; Koester A; Schoepp DD Psychopharmacology (Berl); 2005 Apr; 179(1):284-91. PubMed ID: 15619115 [TBL] [Abstract][Full Text] [Related]
16. Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine. Charney DS; Breier A; Jatlow PI; Heninger GR Psychopharmacology (Berl); 1986; 88(2):133-40. PubMed ID: 3081923 [TBL] [Abstract][Full Text] [Related]
17. Effects of Acute Confinement Stress-induced Hypothalamic-Pituitary Adrenal Axis Activation and Concomitant Peripheral and Central Transforming Growth Factor-β1 Measures in Nonhuman Primates. Coplan JD; Gopinath S; Abdallah CG; Margolis J; Chen W; Scharf BA; Rosenblum LA; Batuman OA; Smith EL Chronic Stress (Thousand Oaks); 2017 Feb; 1():. PubMed ID: 28393139 [TBL] [Abstract][Full Text] [Related]
18. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man. Inder WJ; Ellis MJ; Evans MJ; Donald RA Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616 [TBL] [Abstract][Full Text] [Related]
19. Further characterization of brain 3,4-dihydroxyphenylethyleneglycol (DHPG) formation: dependence on noradrenergic activity and site of formation. Li PP; Warsh JJ; Godse DD Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):26-33. PubMed ID: 3951564 [TBL] [Abstract][Full Text] [Related]
20. Reversal of novelty-induced hyperlocomotion and hippocampal c-Fos expression in GluA1 knockout male mice by the mGluR2/3 agonist LY354740. Procaccini C; Maksimovic M; Aitta-Aho T; Korpi ER; Linden AM Neuroscience; 2013 Oct; 250():189-200. PubMed ID: 23867766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]